 | • レポートコード：20QY06-02125 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、149ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、セファロスポリンのグローバル市場について種類別（第一世代、第二世代、第三世代、第四世代）、用途別（経口、注射）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・セファロスポリン市場の概要 ・世界の主要地域別セファロスポリン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のセファロスポリン市場規模2015-2026：種類別（第一世代、第二世代、第三世代、第四世代） ・世界のセファロスポリン市場規模2015-2026：用途別（経口、注射） ・セファロスポリンの北米市場規模2015-2020 ・セファロスポリンのヨーロッパ市場規模2015-2020 ・セファロスポリンの中国市場規模2015-2020 ・セファロスポリンの日本市場規模2015-2020 ・セファロスポリンの東南アジア市場規模2015-2020 ・セファロスポリンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Union Chempharma、NCPC、Qilu Antibiotics、Lupin Pharmaceuticals、Hospira、Dhanuka Laboratories、Fukang、Dongying Pharmaceutical、Alkem、SALUBRIS、LIVZON、Hetero Drugs、CSPC、TEVA、Orchid Pharma、Taj Pharmaceuticals、Covalent Laboratories、United Laboratories、Aurobindo、Wockhardt、LKPC、HPGC、Huafangpharm） ・セファロスポリンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・セファロスポリンの市場動向・機会・課題 ・調査の結論 |
Cephalosporin is an antibiotic medication commonly prescribed to treat several different types of infections.
The classification of Cephalosporin includes First Generation, Second Generation, Third Generation, Fourth Generation and the proportion of Third Generation in 2016 is about 37.2%, and the proportion is in increasing trend from 2012 to 2016.
Market Analysis and Insights: Global Cephalosporin Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Cephalosporin market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Cephalosporin industry.
Based on our recent survey, we have several different scenarios about the Cephalosporin YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 3835.6 million in 2019. The market size of Cephalosporin will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Cephalosporin Scope and Market Size
The global Cephalosporin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cephalosporin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Cephalosporin market is segmented into
First Generation
Second Generation
Third Generation
Fourth Generation
Segment by Application, the Cephalosporin market is segmented into
Oral
Injection
The Cephalosporin market is analysed and market size information is provided by regions (countries). Segment by Application, the Cephalosporin market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Cephalosporin Market Share Analysis
Cephalosporin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cephalosporin business, the date to enter into the Cephalosporin market, Cephalosporin product introduction, recent developments, etc.
The major vendors covered:
Union Chempharma
NCPC
Qilu Antibiotics
Lupin Pharmaceuticals
Hospira
Dhanuka Laboratories
Fukang
Dongying Pharmaceutical
Alkem
SALUBRIS
LIVZON
Hetero Drugs
CSPC
TEVA
Orchid Pharma
Taj Pharmaceuticals
Covalent Laboratories
United Laboratories
Aurobindo
Wockhardt
LKPC
HPGC
Huafangpharm
1 Cephalosporin Market Overview
1.1 Cephalosporin Product Scope
1.2 Cephalosporin Segment by Type
1.2.1 Global Cephalosporin Sales by Type (2020-2026)
1.2.2 First Generation
1.2.3 Second Generation
1.2.4 Third Generation
1.2.5 Fourth Generation
1.3 Cephalosporin Segment by Application
1.3.1 Global Cephalosporin Sales Comparison by Application (2020-2026)
1.3.2 Oral
1.3.3 Injection
1.4 Cephalosporin Market Estimates and Forecasts (2015-2026)
1.4.1 Global Cephalosporin Sales Growth Rate (2015-2026)
1.4.2 Global Cephalosporin Revenue and Growth Rate (2015-2026)
1.4.3 Global Cephalosporin Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Cephalosporin Industry Impact
1.5.1 How the Covid-19 is Affecting the Cephalosporin Industry
1.5.1.1 Cephalosporin Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Cephalosporin Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Cephalosporin Players to Combat Covid-19 Impact
2 Cephalosporin Estimate and Forecast by Region
2.1 Global Cephalosporin Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Cephalosporin Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Cephalosporin Sales Market Share by Region (2015-2020)
2.2.2 Global Cephalosporin Revenue Market Share by Region (2015-2020)
2.3 Global Cephalosporin Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Cephalosporin Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Cephalosporin Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Cephalosporin Estimates and Projections (2015-2026)
2.4.2 Europe Cephalosporin Estimates and Projections (2015-2026)
2.4.3 China Cephalosporin Estimates and Projections (2015-2026)
2.4.4 Japan Cephalosporin Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Cephalosporin Estimates and Projections (2015-2026)
2.4.6 India Cephalosporin Estimates and Projections (2015-2026)
3 Global Cephalosporin Competition Landscape by Players
3.1 Global Top Cephalosporin Players by Sales (2015-2020)
3.2 Global Top Cephalosporin Players by Revenue (2015-2020)
3.3 Global Cephalosporin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cephalosporin as of 2019)
3.4 Global Cephalosporin Average Price by Company (2015-2020)
3.5 Manufacturers Cephalosporin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Cephalosporin Players (Opinion Leaders)
4 Global Cephalosporin Market Size by Type
4.1 Global Cephalosporin Historic Market Review by Type (2015-2020)
4.1.1 Global Cephalosporin Sales Market Share by Type (2015-2020)
4.1.2 Global Cephalosporin Revenue Market Share by Type (2015-2020)
4.1.3 Global Cephalosporin Price by Type (2014-2020)
4.2 Global Cephalosporin Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Cephalosporin Sales Forecast by Type (2021-2026)
4.2.2 Global Cephalosporin Revenue Forecast by Type (2021-2026)
4.2.3 Global Cephalosporin Price Forecast by Type (2021-2026)
5 Global Cephalosporin Market Size by Application
5.1 Global Cephalosporin Historic Market Review by Application (2015-2020)
5.1.1 Global Cephalosporin Sales Market Share by Application (2015-2020)
5.1.2 Global Cephalosporin Revenue Market Share by Application (2015-2020)
5.1.3 Global Cephalosporin Price by Application (2015-2020)
5.2 Global Cephalosporin Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Cephalosporin Sales Forecast by Application (2021-2026)
5.2.2 Global Cephalosporin Revenue Forecast by Application (2021-2026)
5.2.3 Global Cephalosporin Price Forecast by Application (2021-2026)
3 North America Cephalosporin Market Facts & Figures
3.2 North America Cephalosporin Sales Market Share by Company (2015-2020)
3.3 North America Cephalosporin Sales Market Share by Type (2015-2020)
3.4 North America Cephalosporin Sales Market Share by Application (2015-2020)
4 Europe Cephalosporin Market Facts & Figures
4.2 Europe Cephalosporin Sales Market Share by Company (2015-2020)
4.3 Europe Cephalosporin Sales Market Share by Type (2015-2020)
4.4 Europe Cephalosporin Sales Market Share by Application (2015-2020)
5 China Cephalosporin Market Facts & Figures
5.2 China Cephalosporin Sales Market Share by Company (2015-2020)
5.3 China Cephalosporin Sales Market Share by Type (2015-2020)
5.4 China Cephalosporin Sales Market Share by Application (2015-2020)
6 Japan Cephalosporin Market Facts & Figures
6.2 Japan Cephalosporin Sales Market Share by Company (2015-2020)
6.3 Japan Cephalosporin Sales Market Share by Type (2015-2020)
6.4 Japan Cephalosporin Sales Market Share by Application (2015-2020)
7 Southeast Asia Cephalosporin Market Facts & Figures
7.2 Southeast Asia Cephalosporin Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Cephalosporin Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Cephalosporin Sales Market Share by Application (2015-2020)
8 India Cephalosporin Market Facts & Figures
8.2 India Cephalosporin Sales Market Share by Company (2015-2020)
8.3 India Cephalosporin Sales Market Share by Type (2015-2020)
8.4 India Cephalosporin Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Cephalosporin Business
12.1 Union Chempharma
12.1.1 Union Chempharma Cephalosporin Corporation Information
12.1.2 Union Chempharma Cephalosporin Business Overview and Total Revenue
12.1.3 Union Chempharma Cephalosporin Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Union Chempharma Cephalosporin Products Offered
12.1.5 Union Chempharma Recent Development
12.2 NCPC
12.2.1 NCPC Cephalosporin Corporation Information
12.2.2 NCPC Cephalosporin Business Overview and Total Revenue
12.2.3 NCPC Cephalosporin Sales, Revenue and Gross Margin (2015-2020)
12.2.4 NCPC Cephalosporin Products Offered
12.2.5 NCPC Recent Development
12.3 Qilu Antibiotics
12.3.1 Qilu Antibiotics Cephalosporin Corporation Information
12.3.2 Qilu Antibiotics Cephalosporin Business Overview and Total Revenue
12.3.3 Qilu Antibiotics Cephalosporin Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Qilu Antibiotics Cephalosporin Products Offered
12.3.5 Qilu Antibiotics Recent Development
12.4 Lupin Pharmaceuticals
12.4.1 Lupin Pharmaceuticals Cephalosporin Corporation Information
12.4.2 Lupin Pharmaceuticals Cephalosporin Business Overview and Total Revenue
12.4.3 Lupin Pharmaceuticals Cephalosporin Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Lupin Pharmaceuticals Cephalosporin Products Offered
12.4.5 Lupin Pharmaceuticals Recent Development
12.5 Hospira
12.5.1 Hospira Cephalosporin Corporation Information
12.5.2 Hospira Cephalosporin Business Overview and Total Revenue
12.5.3 Hospira Cephalosporin Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Hospira Cephalosporin Products Offered
12.5.5 Hospira Recent Development
12.6 Dhanuka Laboratories
12.6.1 Dhanuka Laboratories Cephalosporin Corporation Information
12.6.2 Dhanuka Laboratories Cephalosporin Business Overview and Total Revenue
12.6.3 Dhanuka Laboratories Cephalosporin Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Dhanuka Laboratories Cephalosporin Products Offered
12.6.5 Dhanuka Laboratories Recent Development
12.7 Fukang
12.7.1 Fukang Cephalosporin Corporation Information
12.7.2 Fukang Cephalosporin Business Overview and Total Revenue
12.7.3 Fukang Cephalosporin Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Fukang Cephalosporin Products Offered
12.7.5 Fukang Recent Development
12.8 Dongying Pharmaceutical
12.8.1 Dongying Pharmaceutical Cephalosporin Corporation Information
12.8.2 Dongying Pharmaceutical Cephalosporin Business Overview and Total Revenue
12.8.3 Dongying Pharmaceutical Cephalosporin Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Dongying Pharmaceutical Cephalosporin Products Offered
12.8.5 Dongying Pharmaceutical Recent Development
12.9 Alkem
12.9.1 Alkem Cephalosporin Corporation Information
12.9.2 Alkem Cephalosporin Business Overview and Total Revenue
12.9.3 Alkem Cephalosporin Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Alkem Cephalosporin Products Offered
12.9.5 Alkem Recent Development
12.10 SALUBRIS
12.10.1 SALUBRIS Cephalosporin Corporation Information
12.10.2 SALUBRIS Cephalosporin Business Overview and Total Revenue
12.10.3 SALUBRIS Cephalosporin Sales, Revenue and Gross Margin (2015-2020)
12.10.4 SALUBRIS Cephalosporin Products Offered
12.10.5 SALUBRIS Recent Development
12.11 LIVZON
12.11.1 LIVZON Cephalosporin Corporation Information
12.11.2 LIVZON Cephalosporin Business Overview and Total Revenue
12.11.3 LIVZON Cephalosporin Sales, Revenue and Gross Margin (2015-2020)
12.11.4 LIVZON Cephalosporin Products Offered
12.11.5 LIVZON Recent Development
12.12 Hetero Drugs
12.12.1 Hetero Drugs Cephalosporin Corporation Information
12.12.2 Hetero Drugs Cephalosporin Business Overview and Total Revenue
12.12.3 Hetero Drugs Cephalosporin Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Hetero Drugs Cephalosporin Products Offered
12.12.5 Hetero Drugs Recent Development
12.13 CSPC
12.13.1 CSPC Cephalosporin Corporation Information
12.13.2 CSPC Cephalosporin Business Overview and Total Revenue
12.13.3 CSPC Cephalosporin Sales, Revenue and Gross Margin (2015-2020)
12.13.4 CSPC Cephalosporin Products Offered
12.13.5 CSPC Recent Development
12.14 TEVA
12.14.1 TEVA Cephalosporin Corporation Information
12.14.2 TEVA Cephalosporin Business Overview and Total Revenue
12.14.3 TEVA Cephalosporin Sales, Revenue and Gross Margin (2015-2020)
12.14.4 TEVA Cephalosporin Products Offered
12.14.5 TEVA Recent Development
12.15 Orchid Pharma
12.15.1 Orchid Pharma Cephalosporin Corporation Information
12.15.2 Orchid Pharma Cephalosporin Business Overview and Total Revenue
12.15.3 Orchid Pharma Cephalosporin Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Orchid Pharma Cephalosporin Products Offered
12.15.5 Orchid Pharma Recent Development
12.16 Taj Pharmaceuticals
12.16.1 Taj Pharmaceuticals Cephalosporin Corporation Information
12.16.2 Taj Pharmaceuticals Cephalosporin Business Overview and Total Revenue
12.16.3 Taj Pharmaceuticals Cephalosporin Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Taj Pharmaceuticals Cephalosporin Products Offered
12.16.5 Taj Pharmaceuticals Recent Development
12.17 Covalent Laboratories
12.17.1 Covalent Laboratories Cephalosporin Corporation Information
12.17.2 Covalent Laboratories Cephalosporin Business Overview and Total Revenue
12.17.3 Covalent Laboratories Cephalosporin Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Covalent Laboratories Cephalosporin Products Offered
12.17.5 Covalent Laboratories Recent Development
12.18 United Laboratories
12.18.1 United Laboratories Cephalosporin Corporation Information
12.18.2 United Laboratories Cephalosporin Business Overview and Total Revenue
12.18.3 United Laboratories Cephalosporin Sales, Revenue and Gross Margin (2015-2020)
12.18.4 United Laboratories Cephalosporin Products Offered
12.18.5 United Laboratories Recent Development
12.19 Aurobindo
12.19.1 Aurobindo Cephalosporin Corporation Information
12.19.2 Aurobindo Cephalosporin Business Overview and Total Revenue
12.19.3 Aurobindo Cephalosporin Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Aurobindo Cephalosporin Products Offered
12.19.5 Aurobindo Recent Development
12.20 Wockhardt
12.20.1 Wockhardt Cephalosporin Corporation Information
12.20.2 Wockhardt Cephalosporin Business Overview and Total Revenue
12.20.3 Wockhardt Cephalosporin Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Wockhardt Cephalosporin Products Offered
12.20.5 Wockhardt Recent Development
12.21 LKPC
12.21.1 LKPC Cephalosporin Corporation Information
12.21.2 LKPC Cephalosporin Business Overview and Total Revenue
12.21.3 LKPC Cephalosporin Sales, Revenue and Gross Margin (2015-2020)
12.21.4 LKPC Cephalosporin Products Offered
12.21.5 LKPC Recent Development
12.22 HPGC
12.22.1 HPGC Cephalosporin Corporation Information
12.22.2 HPGC Cephalosporin Business Overview and Total Revenue
12.22.3 HPGC Cephalosporin Sales, Revenue and Gross Margin (2015-2020)
12.22.4 HPGC Cephalosporin Products Offered
12.22.5 HPGC Recent Development
12.23 Huafangpharm
12.23.1 Huafangpharm Cephalosporin Corporation Information
12.23.2 Huafangpharm Cephalosporin Business Overview and Total Revenue
12.23.3 Huafangpharm Cephalosporin Sales, Revenue and Gross Margin (2015-2020)
12.23.4 Huafangpharm Cephalosporin Products Offered
12.23.5 Huafangpharm Recent Development
13 Cephalosporin Manufacturing Cost Analysis
13.1 Cephalosporin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Cephalosporin
13.4 Cephalosporin Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Cephalosporin Distributors List
14.3 Cephalosporin Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Cephalosporin Sales (MT) Growth Rate by Type (2020-2026)
Table 2. Global Cephalosporin Sales (MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Cephalosporin Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Cephalosporin Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Cephalosporin Players to Combat Covid-19 Impact
Table 8. Global Market Cephalosporin Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Cephalosporin Sales (MT) by Region (2015-2020)
Table 10. Global Cephalosporin Sales Market Share by Region (2015-2020)
Table 11. Global Cephalosporin Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Cephalosporin Revenue Share by Region (2015-2020)
Table 13. Global Cephalosporin Sales (MT) Forecast by Region (2021-2026)
Table 14. Global Cephalosporin Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Cephalosporin Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Cephalosporin Revenue Share Forecast by Region (2021-2026)
Table 17. Global Cephalosporin (MT) of Key Companies (2015-2020)
Table 18. Global Cephalosporin Sales Share by Company (2015-2020)
Table 19. Global Cephalosporin Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Cephalosporin Revenue Share by Company (2015-2020)
Table 21. Global Cephalosporin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cephalosporin as of 2019)
Table 22. Global Cephalosporin Average Price (USD/Kg) of Key Company (2015-2020)
Table 23. Manufacturers Cephalosporin Manufacturing Sites and Area Served
Table 24. Manufacturers Cephalosporin Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Cephalosporin Players
Table 27. Global Cephalosporin Sales (MT) by Type (2015-2020)
Table 28. Global Cephalosporin Sales Share by Type (2015-2020)
Table 29. Global Cephalosporin Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Cephalosporin Price (MT) by Type (2015-2020)
Table 31. Global Cephalosporin Sales Share by Type (2021-2026)
Table 32. Global Cephalosporin Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Cephalosporin Revenue Share by Type (2021-2026)
Table 34. Global Cephalosporin Price (MT) by Type (2021-2026)
Table 35. Global Cephalosporin Sales (MT) by Application (2015-2020)
Table 36. Global Cephalosporin Sales Share by Application (2015-2020)
Table 37. Global Cephalosporin Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Cephalosporin Price (MT) by Application (2015-2020)
Table 39. Global Cephalosporin Sales (MT) by Application (2021-2026)
Table 40. Global Cephalosporin Sales Share by Application (2021-2026)
Table 41. Global Cephalosporin Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Cephalosporin Revenue Share by Application (2021-2026)
Table 43. Global Cephalosporin Price (MT) by Application (2021-2026)
Table 44. United States Cephalosporin Sales (MT) by Company (2015-2020)
Table 45. United States Cephalosporin Sales Market Share by Company (2015-2020)
Table 46. United States Cephalosporin Sales (MT) by Type (2015-2020)
Table 47. United States Cephalosporin Sales Market Share by Type (2015-2020)
Table 48. United States Cephalosporin Sales (MT) by Application (2015-2020)
Table 49. United States Cephalosporin Sales Market Share by Application (2015-2020)
Table 50. Europe Cephalosporin Sales (MT) by Company (2015-2020)
Table 51. Europe Cephalosporin Sales Market Share by Company (2015-2020)
Table 52. Europe Cephalosporin Sales (MT) by Type (2015-2020)
Table 53. Europe Cephalosporin Sales Market Share by Type (2015-2020)
Table 54. Europe Cephalosporin Sales (MT) by Application (2015-2020)
Table 55. Europe Cephalosporin Sales Market Share by Type (2015-2020)
Table 56. China Cephalosporin Sales (MT) by Company (2015-2020)
Table 57. China Cephalosporin Sales Market Share by Company (2015-2020)
Table 58. China Cephalosporin Sales (MT) by Type (2015-2020)
Table 59. China Cephalosporin Sales Market Share by Type (2015-2020)
Table 60. China Cephalosporin Sales (MT) by Application (2015-2020)
Table 61. China Cephalosporin Sales Market Share by Application (2015-2020)
Table 62. Japan Cephalosporin Sales (MT) by Company (2015-2020)
Table 63. Japan Cephalosporin Sales Market Share by Company (2015-2020)
Table 64. Japan Cephalosporin Sales (MT) by Type (2015-2020)
Table 65. Japan Cephalosporin Sales Market Share by Type (2015-2020)
Table 66. Japan Cephalosporin Sales (MT) by Application (2015-2020)
Table 67. Japan Cephalosporin Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Cephalosporin Sales (MT) by Company (2015-2020)
Table 69. Southeast Asia Cephalosporin Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Cephalosporin Sales (MT) by Type (2015-2020)
Table 71. Southeast Asia Cephalosporin Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Cephalosporin Sales (MT) by Type (2015-2020)
Table 73. Southeast Asia Cephalosporin Sales Market Share by Application (2015-2020)
Table 74. India Cephalosporin Sales (MT) by Company (2015-2020)
Table 75. India Cephalosporin Sales Market Share by Company (2015-2020)
Table 76. India Cephalosporin Sales (MT) by Type (2015-2020)
Table 77. India Cephalosporin Sales Market Share by Type (2015-2020)
Table 78. India Cephalosporin Sales (MT) by Application (2015-2020)
Table 79. India Cephalosporin Sales Market Share by Application (2015-2020)
Table 80. Union Chempharma Corporation Information
Table 81. Union Chempharma Description and Business Overview
Table 82. Union Chempharma Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Union Chempharma Cephalosporin Product
Table 84. Union Chempharma Recent Development
Table 85. NCPC Corporation Information
Table 86. NCPC Description and Business Overview
Table 87. NCPC Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. NCPC Cephalosporin Product
Table 89. NCPC Recent Development
Table 90. Qilu Antibiotics Corporation Information
Table 91. Qilu Antibiotics Description and Business Overview
Table 92. Qilu Antibiotics Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Qilu Antibiotics Cephalosporin Product
Table 94. Qilu Antibiotics Recent Development
Table 95. Lupin Pharmaceuticals Corporation Information
Table 96. Lupin Pharmaceuticals Description and Business Overview
Table 97. Lupin Pharmaceuticals Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Lupin Pharmaceuticals Cephalosporin Product
Table 99. Lupin Pharmaceuticals Recent Development
Table 100. Hospira Corporation Information
Table 101. Hospira Description and Business Overview
Table 102. Hospira Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. Hospira Cephalosporin Product
Table 104. Hospira Recent Development
Table 105. Dhanuka Laboratories Corporation Information
Table 106. Dhanuka Laboratories Description and Business Overview
Table 107. Dhanuka Laboratories Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. Dhanuka Laboratories Cephalosporin Product
Table 109. Dhanuka Laboratories Recent Development
Table 110. Fukang Corporation Information
Table 111. Fukang Description and Business Overview
Table 112. Fukang Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 113. Fukang Cephalosporin Product
Table 114. Fukang Recent Development
Table 115. Dongying Pharmaceutical Corporation Information
Table 116. Dongying Pharmaceutical Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. Dongying Pharmaceutical Description and Business Overview
Table 118. Dongying Pharmaceutical Cephalosporin Product
Table 119. Dongying Pharmaceutical Recent Development
Table 120. Alkem Corporation Information
Table 121. Alkem Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 122. Alkem Description and Business Overview
Table 123. Alkem Cephalosporin Product
Table 124. Alkem Recent Development
Table 125. SALUBRIS Corporation Information
Table 126. SALUBRIS Description and Business Overview
Table 127. SALUBRIS Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 128. SALUBRIS Cephalosporin Product
Table 129. SALUBRIS Recent Development
Table 130. LIVZON Corporation Information
Table 131. LIVZON Description and Business Overview
Table 132. LIVZON Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 133. LIVZON Cephalosporin Product
Table 134. LIVZON Recent Development
Table 135. Hetero Drugs Corporation Information
Table 136. Hetero Drugs Description and Business Overview
Table 137. Hetero Drugs Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 138. Hetero Drugs Cephalosporin Product
Table 139. Hetero Drugs Recent Development
Table 140. CSPC Corporation Information
Table 141. CSPC Description and Business Overview
Table 142. CSPC Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 143. CSPC Cephalosporin Product
Table 144. CSPC Recent Development
Table 145. TEVA Corporation Information
Table 146. TEVA Description and Business Overview
Table 147. TEVA Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 148. TEVA Cephalosporin Product
Table 149. TEVA Recent Development
Table 150. Orchid Pharma Corporation Information
Table 151. Orchid Pharma Description and Business Overview
Table 152. Orchid Pharma Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 153. Orchid Pharma Cephalosporin Product
Table 154. Orchid Pharma Recent Development
Table 155. Taj Pharmaceuticals Corporation Information
Table 156. Taj Pharmaceuticals Description and Business Overview
Table 157. Taj Pharmaceuticals Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 158. Taj Pharmaceuticals Cephalosporin Product
Table 159. Taj Pharmaceuticals Recent Development
Table 160. Covalent Laboratories Corporation Information
Table 161. Covalent Laboratories Description and Business Overview
Table 162. Covalent Laboratories Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 163. Covalent Laboratories Cephalosporin Product
Table 164. Covalent Laboratories Recent Development
Table 165. United Laboratories Corporation Information
Table 166. United Laboratories Description and Business Overview
Table 167. United Laboratories Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 168. United Laboratories Cephalosporin Product
Table 169. United Laboratories Recent Development
Table 170. Aurobindo Corporation Information
Table 171. Aurobindo Description and Business Overview
Table 172. Aurobindo Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 173. Aurobindo Cephalosporin Product
Table 174. Aurobindo Recent Development
Table 175. Wockhardt Corporation Information
Table 176. Wockhardt Description and Business Overview
Table 177. Wockhardt Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 178. Wockhardt Cephalosporin Product
Table 179. Wockhardt Recent Development
Table 180. LKPC Corporation Information
Table 181. LKPC Description and Business Overview
Table 182. LKPC Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 183. LKPC Cephalosporin Product
Table 184. LKPC Recent Development
Table 185. HPGC Corporation Information
Table 186. HPGC Description and Business Overview
Table 187. HPGC Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 188. HPGC Cephalosporin Product
Table 189. HPGC Recent Development
Table . Huafangpharm Corporation Information
Table . Huafangpharm Description and Business Overview
Table . Huafangpharm Cephalosporin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table . Huafangpharm Cephalosporin Product
Table . Huafangpharm Recent Development
Table 195. Production Base and Market Concentration Rate of Raw Material
Table 196. Key Suppliers of Raw Materials
Table 197. Cephalosporin Distributors List
Table 198. Cephalosporin Customers List
Table 199. Market Key Trends
Table 200. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 201. Key Challenges
Table 202. Research Programs/Design for This Report
Table 203. Key Data Information from Secondary Sources
Table 204. Key Data Information from Primary Sources
List of Figures
Figure 1. Cephalosporin Product Picture
Figure 2. Global Cephalosporin Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Cephalosporin Market Share by Application in 2020 & 2026
Figure 6. Oral Examples
Figure 7. Injection Examples
Figure 8. Global Cephalosporin Sales (MT) Growth Rate (2015-2026)
Figure 9. Global Cephalosporin Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Cephalosporin Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 11. Global Cephalosporin Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Cephalosporin Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Cephalosporin Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Cephalosporin Sales (MT) Growth Rate (2015-2026)
Figure 15. Europe Cephalosporin Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Cephalosporin Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Cephalosporin Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Cephalosporin Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Cephalosporin Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Cephalosporin Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Cephalosporin Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Cephalosporin Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Cephalosporin Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Cephalosporin Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Cephalosporin Players Market Share by Revenue in Cephalosporin 2015 & 2019
Figure 26. Cephalosporin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Cephalosporin Revenue Share by Type (2015-2020)
Figure 28. Global Cephalosporin Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Cephalosporin Revenue Share by Application (2015-2020)
Figure 30. Global Cephalosporin Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Cephalosporin Sales Market Share by Type in 2019
Figure 32. United States Cephalosporin Sales Market Share by Type in 2019
Figure 33. Europe Cephalosporin Sales Market Share by Company in 2019
Figure 34. Europe Cephalosporin Sales Market Share by Type in 2019
Figure 35. Europe Cephalosporin Sales Market Share by Application in 2019
Figure 36. China Cephalosporin Sales Market Share by Company in 2019
Figure 37. China Cephalosporin Sales Market Share by Type in 2019
Figure 38. China Cephalosporin Sales Market Share by Application in 2019
Figure 39. Japan Cephalosporin Sales Market Share by Company in 2019
Figure 40. Japan Cephalosporin Sales Market Share by Type in 2019
Figure 41. Japan Cephalosporin Sales Market Share by Application in 2019
Figure 42. Southeast Asia Cephalosporin Sales Market Share by Company in 2019
Figure 43. Southeast Asia Cephalosporin Sales Market Share by Type in 2019
Figure 44. Southeast Asia Cephalosporin Sales Market Share by Application in 2019
Figure 45. India Cephalosporin Sales Market Share by Company in 2019
Figure 46. India Cephalosporin Sales Market Share by Type in 2019
Figure 47. India Cephalosporin Sales Market Share by Application in 2019
Figure 48. Union Chempharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. NCPC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Qilu Antibiotics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Lupin Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Hospira Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Dhanuka Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Fukang Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Dongying Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Alkem Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. SALUBRIS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. LIVZON Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Hetero Drugs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. CSPC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. TEVA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Orchid Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Taj Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Covalent Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. United Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Aurobindo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Wockhardt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. LKPC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 69. HPGC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. Huafangpharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 71. Key Raw Materials Price Trend
Figure 72. Manufacturing Cost Structure of Cephalosporin
Figure 73. Manufacturing Process Analysis of Cephalosporin
Figure 74. Cephalosporin Industrial Chain Analysis
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Porter's Five Forces Analysis
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
経口セファロスポリンの世界市場レポート2020 Market Analysis and Insights: Global Oral Cephalosporin Market The global Oral Cephalosporin market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Oral Cephalosporin Scope and Market Size The global Oral Cephal…- 経口セファロスポリンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Oral Cephalosporin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oral Cephalosporin market …
- 発電の世界市場レポート2020 Electricity Generation market includes power generation companies that produce electricity using a variety of sources such as hydro, fossil fuels, solar, nuclear wind and biomass. Natural gas and renewable energy sources are increasingly being used For generating electricity to reduce the greenhouse…
- 発電・送電・配電の世界市場レポート2020 The generation, transmission, and distribution industry includes establishments involved in generating, transmitting, and distributing electric power. Companies in this industry operate generation facilities that produce electricity, transmission systems that convey electricity from generation facil…
- 次世代メモリの世界市場レポート2020 The growth of this market can be attributed to the increasing enterprise storage application; demand for universal memory devices; need for high bandwidth, low power consumption, and highly scalable memory device for technologies such as artificial intelligence (AI), Internet of Things (IoT), and bi…